Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
Public ClinicalTrials.gov record NCT00343733. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week Open-Label Study With 3 Within-Patient Double-Blind Placebo-Controlled Periods to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
Study identification
- NCT ID
- NCT00343733
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Cephalon
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- OraVescent Fentanyl Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2006
- Primary completion
- Not listed
- Completion
- Jun 30, 2007
- Last update posted
- May 8, 2014
2006 – 2007
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hot Springs Pain Clinic | Hot Springs | Arkansas | 71913 | — |
| Samaritan Center for Medical | Los Gatos | California | 92032 | — |
| Pacific Neuroscience Medical Group, Inc. | Oxnard | California | 93030 | — |
| Centre for Rheumatology | Fort Lauderdale | Florida | 33334 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Atlas Research | Orlando | Florida | 32806 | — |
| Gold Coast Research, LLC | Plantation | Florida | 33324 | — |
| Comprehensive Pain Care, PC | Marietta | Georgia | 30060 | — |
| Drug Studies America | Marietta | Georgia | 30066 | — |
| Best Clinical Trials, Inc. | New Orleans | Louisiana | 70065 | — |
| Best Clinical Trials, LLC | New Orleans | Louisiana | 70115 | — |
| Brigham Women's Hospital | Boston | Massachusetts | 02115 | — |
| Pain Management Associates | Independence | Missouri | 64055 | — |
| Montana Neuroscience Institute | Missoula | Montana | 59802 | — |
| Lovelace Scientific Resources | Albuquerque | New Mexico | 87108 | — |
| Five Towns Neuroscience Research | Lawrence | New York | 11599 | — |
| PharmQuest | Greensboro | North Carolina | 27401 | — |
| Center for Clinical Research | Winston-Salem | North Carolina | 27103 | — |
| Legacy Emanuel Pain Management, PC | Portland | Oregon | 97227 | — |
| Clinical Research Center | West Reading | Pennsylvania | 19611 | — |
| Advanced Pain Management | Virginia Beach | Virginia | 23454 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00343733, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00343733 live on ClinicalTrials.gov.